Long-term persistence of anti-HBs after hepatitis B immunization in thalassaemic patients
- 1 September 1992
- journal article
- research article
- Published by Springer Nature in Infection
- Vol. 20 (5) , 276-278
- https://doi.org/10.1007/bf01710794
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Immunogenicity and Efficacy of Anti-Hepatitis B Vaccines in Hemodialysis PatientsNephron, 1992
- Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccineVaccine, 1990
- Yeast-derived hepatitis B vaccine in thalassaemic patients: a preliminary report.1987
- Immunogenicity and efficacy of hepatitis B vaccine in normal children and in patients with thalassaemiaJournal of Infection, 1983
- Chronic liver disease in transfusion-dependent thalassaemia: hepatitis B virus marker studies.Journal of Clinical Pathology, 1980
- EPIDEMIOLOGY OF HBV-ASSOCIATED DELTA AGENT: GEOGRAPHICAL DISTRIBUTION OF ANTI-DELTA AND PREVALENCE IN POLYTRANSFUSED HBsAg CARRIERSThe Lancet, 1980
- Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.BMJ, 1978